Status: Phase 3
Entry Type: Antibody
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Adenocarcinoma; Pancreatic Neoplasms Phase 1 ClinicalTrials
Pancreatic Neoplasms Phase 1/Phase 2 ClinicalTrials
Pancreatic Neoplasms Phase 3 ClinicalTrials
CONTENTS